Abstract:
At present, the technology of treatment with autologous platelet-rich plasma (APRP) is widely used in medicine. Due to the natural properties of platelet-rich plasma, its
introduction into the body is one of the most promising procedures in tissue restoration. After platelet destruction, APRP contains a-granules, from which, after activation, many factors are released, such as transforming growth factor-beta (TGF-P), vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) [1]. The effectiveness of APRP in wound healing and tissue restoration in maxillofacial surgery, cardiac surgery, ophthalmology, orthopedics, plastic surgery, sports medicine and
cosmetology has been proven [2
